Is increasing HPV infection awareness promoting increased vaccine compliance?

Internet Journal of Advanced Nursing Practice

Volumn 11, Issue 1, 2010, Pages

  Rodriguez, Melinda C ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON   (United States)

Author keywords

Awareness; Cervarix; Cervical cancer; Compliance; Gardasil; Genital warts; Human papilloma virus; Promiscuity; Sexually transmitted infection

Indexed keywords

EID: 78649248895     PISSN: None     EISSN: 15236064     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Brabin L, Roberts, SA, Farzaneh, F, Kitchener, HC. Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes. Vaccine 2006; 3087-3094. (s)
2. Brewer, NT, Fazekas, KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine 2007; 107-114. (s)
3. Centers for Disease Control. HPV vaccine questions and answers. [Cited March 2010] Available from URL: http://www.cdc.gov/vaccines/vpd-vac/hpv/vac-faqs.htm (s)
4. Centers for Disease Control. Vaccine safety: Reports of health concerns following HPV vaccination. [Cited 2009] Available from URL http://www.cdc.gov/vaccinesafety/Vaccines/HPV/Gardasil.html (s)
5. Coren, JS. Incorporating HPV vaccination into your practice. [Cited March 2009] Available from URL:http://www.cecity.com/aoa/women_well/mar_09/print4pdf (s)
6. Charo, RA. Politics, parents and prophylaxis: Mandating HPV vaccination in the United States. NEJM 2007; 356: 1905-1908. (s)
7. Dekker, AH. Fostering acceptance of human papillomavirus vaccines. J. Am. Osteopathic Association 2006; 106:S14-S18. (s)
8. Duval et al. Cervical cancer prevention by vaccination: Nurse's knowledge, attitudes and intentions. J. of Adv Nursing 2009; 65:499-508. (s)
9. Ferris, D, Horn, L, Waller, JL. Parental acceptance of a mandatory human papillomavirus (HPV) vaccination program. J Am Board of Fam Medicine 2010; 23: 220-229. (s)
10. Gostin, LO, DeAngelis, CD. Mandatory HPV vaccination: Public health vs. public wealth. JAMA 2007; 297: 1921-1923. (s)
11. Harper et al. Sustained efficacy up to 4-5 years of a bivalent L1virus-like particle vaccine against human papillomavirus types 16 and 18. Lancet 2006; 367:1247-1255. (s)
12. Hershey, JH, Velez, LF. Public health issues related to HPV vaccination. J Pub Health Management Practice 2009; 15:384-392. (s)
13. Herzog, TJ, Huh, WK, Downs, LS, et al. Initial lessons learned in HPV vaccination. Gyn Oncology 2008; 109: S4-S11. (s)
14. Lehmann, C, Benson, PA. Vaccine adherence in adolescents. Clin Pediatrics 2009; 48: 801-811. (s)
15. Kaiser Family Foundation. HPV vaccine: Implementation and financing policy in the U.S.[Cited 2008 March] Available from URL: http://www.kff.org/womenshealth/upload/7602_02.pdf (s)
16. Maville, J, Huerta, C. Health promotion in nursing. 2nd ed. New York: Del Mar Learning; 2008. (s)
17. Miller, MM, Wilson, JM, Waldrop, J. Current acceptance of the HPV vaccine. The Nurse Practitioner 2008; 33:19-22. (s)
18. Riedesel, JM, Rosenthal, SL, Zimet, GD, Bernstein, DI, Huang, B, Lan, D, Kahn, JA. Attitudes about human papillomavirus vaccine among family physicians. J of Pediatric Adolescent and Gynecology 2005; 18: 391-398. (s)